SZSE Ticker: 002099

Zhejiang Hisoar Pharmaceutical Co., Ltd.

浙江海翔药业股份有限公司

海翔药业

HISOAR

Listing Date: 2006-12-26

Board: SME

Industry Classification: Manufacturing

In 2021, A-share ESG Information Disclosure Over 1,000 Listed Companies Concentrate on Green and Sustainable Development

In 2021, A-share ESG Information Disclosure Over 1,000 Listed Companies Concentrate on Green and Sustainable Development

In 2021, A-Share ESG Information Disclosure Over 1,000 Listed Companies Concentrate on Green and Sustainable Development of ESGA Stock ESG Concept_Sina Technology_Sina Network

On May 16th, 6 shares pre-market favorable announcement express CFi.CN Zhongcai Network

A number of listed companies disclosed strategic cooperation plans

On the evening of May 15th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net

Promote product structure optimization and upgrade Haixiang Pharmaceutical signed a major strategic cooperation agreement

Evening Announcements May 15 These announcements are worth seeing

Evening Announcement Hotspot Tracking: The relocation of the Asian Cup will have a greater impact on ST Mingcheng – yqqlm

Evening Announcements May 15 These announcements are worth seeing

Listed company evening announcement express on May 15_Sina Finance_Sina.com

Evening Announcements May 15 These announcements are worth seeing

Featured Announcement: Zhongsheng Pharmaceutical's oral anti-coronavirus innovative drug RAY1216 was approved for clinical trial; Tongce Medical acquired 29.75% of Heren Technology

On the evening of May 15th, Shanghai and Shenzhen listed companies announced the latest express of major events

Highlights of the announcement on the evening of May 15: Tongce Medical's acquisition of 29.75% of Heren Technology will become the largest shareholder

The latest announcement of Haixiang Pharmaceutical: Signing a strategic cooperation agreement with Xinkaiyuan_Stock News_Market Gold Online

Haixiang Pharmaceutical and Xinkaiyuan signed a strategic cooperation agreement

Haixiang Pharmaceutical (002099): Signing a Strategic Cooperation Agreement- CFi.CN China Finance Network

Aoxiang Pharmaceutical's board secretary replied: Qizheng Pharmaceutical's related tablet production lines have not passed the GMP compliance inspection

Haixiang Pharmaceutical: There is no cooperation between the company and Real Biology_Oriental Fortune Net

Wansheng Co., Ltd. (603010): Zhejiang Wansheng Co., Ltd. 2021 Independent Director Debriefing Report- CFi.CN Zhongcai Network

Want to see more data? Registered subscribers can see all the data.